top of page
THROMBINNOV accelerates the development of innovative therapies by evaluating and de-risking their hemorrhagic and thrombotic risks as early as the preclinical phase.
Our experts work as an extension of your team to understand your objectives and design the most relevant study strategy for the development, characterization, and validation of your molecule or medical device.
Service
20+ models spanning thrombosis, hemostasis and blood-material interactions.
Dynamic models integrating shear stress and blood response.
Study strategies designed around each molecule, device or mechanism.
Data designed to support go/no-go, optimization and validation decisions.
À propos
bottom of page